Stock listing
Munich:1JA1 Jaguar Health, Inc. Aktie
German listing (Munich) of Jaguar Health, Inc. · home listing NASDAQ:JAGX
Follow Jaguar Health, Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:JAGX
$0.407 USD -0.092 (-18.4%)
Close on Nov 5, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:JAGX
- Day range
- $0.370 – $0.480 USDNov 5, 2026
- Volume
- 1.36M sharesNov 5, 2026
- Market cap
- $945,845 USDAt the close on Nov 5, 2026 · price × 2.32M shares outstanding
- 52-week range
- $0.370 – $1,102.500 USDLowest and highest trades, Nov 6, 2025 – Nov 5, 2026
- Traded on an average day
- $24.80M USDMedian day 228,115 shares · last 3 months, Aug 5, 2026 – Nov 5, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:JAGX · Home | $0.407 USD | -0.092 (-18.4%) | 1,364,045 | $0.480 | $0.480 | $0.370 | $0.499 | Close on Nov 5, 2026 |
Daily closes
Last 3 months, Aug 5, 2026 – Nov 5, 2026 · NASDAQ:JAGX · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.407 | -0.092 | -18.4% | $0.480 | $0.480 | $0.370 | 1,364,045 | |
| $0.499 | -0.059 | -10.5% | $0.540 | $0.546 | $0.450 | 1,207,912 | |
| $0.558 | -0.327 | -36.9% | $0.640 | $0.686 | $0.514 | 3,288,747 | |
| $0.884 | -0.736 | -45.4% | $0.960 | $0.975 | $0.810 | 2,140,833 | |
| $1.620 | -0.420 | -20.6% | $2.000 | $2.000 | $1.600 | 383,566 | |
| $2.040 | -0.060 | -2.9% | $2.080 | $2.085 | $2.000 | 291,710 | |
| $2.100 | -0.140 | -6.3% | $2.240 | $2.240 | $2.060 | 234,114 | |
| $2.240 | -0.130 | -5.5% | $2.420 | $2.420 | $2.110 | 267,995 | |
| $2.370 | +0.330 | +16.2% | $2.010 | $2.708 | $2.000 | 2,351,826 | |
| $2.040 | -0.110 | -5.1% | $2.050 | $2.088 | $2.030 | 130,109 | |
| $2.150 | -0.130 | -5.7% | $2.230 | $2.320 | $2.150 | 222,228 | |
| $2.280 | -0.350 | -13.3% | $2.580 | $2.660 | $2.250 | 504,512 | |
| $2.630 | -0.190 | -6.7% | $2.750 | $2.820 | $2.610 | 268,708 | |
| $2.820 | -0.705 | -20.0% | $3.270 | $3.320 | $2.800 | 523,211 | |
| $3.525 | -1.065 | -23.2% | $3.320 | $4.200 | $3.250 | 887,989 | |
| $4.590 | +0.410 | +9.8% | $3.940 | $4.650 | $3.940 | 438,852 | |
| $4.180 | +0.020 | +0.5% | $3.840 | $4.350 | $3.730 | 1,261,425 | |
| $4.160 | -0.480 | -10.3% | $4.350 | $4.410 | $4.070 | 441,956 | |
| $4.640 | -0.150 | -3.1% | $4.830 | $4.830 | $4.315 | 491,018 | |
| $4.790 | +0.260 | +5.7% | $4.560 | $5.330 | $4.470 | 1,090,975 | |
| $4.530 | -0.470 | -9.4% | $4.820 | $4.940 | $4.365 | 590,324 | |
| $5.000 | -0.620 | -11.0% | $5.240 | $5.497 | $4.910 | 1,204,959 | |
| $5.620 | +0.890 | +18.8% | $6.560 | $7.270 | $5.340 | 27,071,693 | |
| $4.730 | +1.070 | +29.2% | $4.270 | $6.000 | $4.100 | 21,895,700 | |
| $3.660 | -0.290 | -7.3% | $4.150 | $4.296 | $3.500 | 598,907 | |
| $3.950 | -0.550 | -12.2% | $4.340 | $4.480 | $3.822 | 471,265 | |
| $4.500 | -0.820 | -15.4% | $5.040 | $5.140 | $4.410 | 732,255 | |
| $5.320 | -0.700 | -11.6% | $5.370 | $6.100 | $5.000 | 943,862 | |
| $6.020 | -1.680 | -21.8% | $6.990 | $7.250 | $5.800 | 1,413,281 | |
| $7.700 | +0.640 | +9.1% | $9.090 | $12.100 | $6.800 | 30,018,781 | |
| $7.060 | -1.850 | -20.8% | $7.030 | $7.720 | $6.021 | 2,081,815 | |
| $8.910 | -25.550 | -74.1% | $15.430 | $19.460 | $8.500 | 11,664,896 | |
| $34.460 | +31.790 | +1190.6% | $2.830 | $41.530 | $2.750 | 27,949,319 | |
| $2.670 | -0.040 | -1.5% | $2.870 | $2.870 | $2.480 | 74,040 | |
| $2.710 | -0.040 | -1.5% | $2.760 | $3.160 | $2.650 | 234,002 | |
| $2.750 | -0.744 | -21.3% | $3.700 | $3.700 | $2.350 | 261,043 | |
| $3.494 | +0.125 | +3.7% | $3.525 | $4.664 | $3.140 | 19,687 | |
| $3.369 | -1.415 | -29.6% | $4.350 | $4.523 | $2.999 | 9,465 | |
| $4.784 | +0.074 | +1.6% | $4.647 | $5.033 | $4.470 | 2,007 | |
| $4.710 | -0.075 | -1.6% | $4.883 | $4.883 | $4.374 | 1,826 | |
| $4.785 | -0.710 | -12.9% | $5.504 | $5.504 | $4.644 | 3,374 | |
| $5.495 | -0.718 | -11.6% | $6.377 | $6.377 | $4.877 | 2,540 | |
| $6.213 | -2.739 | -30.6% | $7.586 | $7.586 | $6.000 | 4,330 | |
| $8.952 | -1.464 | -14.1% | $10.155 | $10.212 | $8.574 | 12,303 | |
| $10.416 | -0.532 | -4.9% | $11.490 | $11.490 | $10.281 | 630 | |
| $10.949 | -0.017 | -0.2% | $11.250 | $11.339 | $10.635 | 528 | |
| $10.965 | -0.902 | -7.6% | $11.925 | $12.375 | $10.769 | 474 | |
| $11.867 | -0.282 | -2.3% | $11.784 | $11.997 | $11.255 | 214 | |
| $12.149 | -0.826 | -6.4% | $12.840 | $12.900 | $11.925 | 714 | |
| $12.975 | -0.816 | -5.9% | $14.699 | $14.699 | $12.975 | 446 | |
| $13.791 | -0.083 | -0.6% | $13.950 | $15.450 | $13.530 | 1,317 | |
| $13.874 | +0.194 | +1.4% | $13.650 | $14.508 | $12.977 | 253 | |
| $13.680 | +0.668 | +5.1% | $13.350 | $15.599 | $12.599 | 1,152 | |
| $13.013 | -0.090 | -0.7% | $13.050 | $13.919 | $12.371 | 341 | |
| $13.103 | -0.762 | -5.5% | $13.050 | $13.647 | $12.455 | 319 | |
| $13.865 | -0.783 | -5.3% | $14.550 | $14.703 | $13.257 | 1,024 | |
| $14.648 | +1.464 | +11.1% | $12.774 | $15.450 | $12.150 | 1,182 | |
| $13.184 | -0.556 | -4.1% | $13.500 | $13.770 | $12.900 | 541 | |
| $13.740 | +1.993 | +17.0% | $11.550 | $15.000 | $11.111 | 5,470 | |
| $11.747 | +0.347 | +3.0% | $11.760 | $12.150 | $11.100 | 481 | |
| $11.400 | -0.351 | -3.0% | $11.550 | $12.471 | $10.875 | 652 | |
| $11.751 | -0.765 | -6.1% | $12.348 | $12.614 | $11.550 | 535 | |
| $12.516 | -1.736 | -12.2% | $14.994 | $14.994 | $12.330 | 970 | |
| $14.252 | +0.160 | +1.1% | $14.550 | $14.697 | $14.100 | 227 | |
| $14.091 | -1.734 | -11.0% | $15.900 | $15.900 | $13.952 | 458 | |
| $15.825 | +0.825 | +5.5% | $15.695 | $16.350 | $14.550 | 753 |
- Ticker
- Munich:1JA1
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Munich
- Currency
- EUR
What changed lately
Latest news release · Nov 2, 2026
CSO of Napo Pharmaceuticals, a Jaguar Health Family Company, and Clinical Investigators Evaluating Crofelemer Conduct Panel Discussion at Pediatric Gastroenterology Conference in Dubai (UAE)
Latest earnings call · Aug 19, 2026
Jaguar Health (NASDAQ:JAGX) Q2 2026 Earnings Call
Replay and transcript
Latest deck · May 26, 2026
Q1 2026 Earnings Presentation
Earnings · 20 slides
Calls
Replays
Jaguar Health (NASDAQ:JAGX) Q2 2026 Earnings Call
Wed, Aug 19, 2026 · 4:30 PM ET
Watch TranscriptJaguar Health (NASDAQ:JAGX) Q1 2026 Earnings Call
Tue, May 26, 2026 · 8:30 AM ET
Watch TranscriptJaguar Health (NASDAQ:JAGX) Q4 2025 Earnings Call
Fri, Apr 10, 2026 · 8:30 AM ET
Watch Transcript
Latest news
CSO of Napo Pharmaceuticals, a Jaguar Health Family Company, and Clinical Investigators Evaluating Crofelemer Conduct Panel Discussion at Pediatric Gastroenterology Conference in Dubai (UAE)
Nov 2, 2026
Closed $0.884 (-45.4%) on Nov 2, 2026
Jaguar Health's Crofelemer Shows Benefit for Intestinal Failure (IF) in Third Rare Congenital Enteropathy Disorder
Oct 21, 2026
Closed $2.28 (-13.3%) on Oct 21, 2026
Jaguar Health Provides Update Regarding Special Stock Dividend
Oct 14, 2026
Closed $4.59 (+9.8%) on Oct 15, 2026
Positive Preliminary Results Presented at Annual American College of Gastroenterology Meeting for Open-Label Study in Adult Short Bowel Syndrome Patients with Intestinal Failure (SBS-IF) with Jaguar Health's Crofelemer
Oct 14, 2026
Closed $4.18 (+0.5%) on Oct 14, 2026
Reminder: Today, October 13, 2026, is the Record Date for Jaguar Health's Special Stock Dividend
Oct 13, 2026
Closed $4.16 (-10.3%) on Oct 13, 2026
Napo Pharmaceuticals, a Jaguar Health Family Company, Sponsoring Intestinal Failure Panel Discussion at Pediatric Gastroenterology Conference in Abu Dhabi
Oct 6, 2026
Closed $5.62 (+18.8%) on Oct 6, 2026
Jaguar Health Announces a Special Stock Dividend
Oct 2, 2026
Closed $4.73 (+29.2%) on Oct 5, 2026
Preliminary Results of Open-Label Study in Adult Short Bowel Syndrome Patients with Intestinal Failure (SBS-IF) with Jaguar Health's Crofelemer Accepted for Presentation at Annual American College of Gastroenterology Meeting
Sep 29, 2026
Closed $5.32 (-11.6%) on Sep 29, 2026
Jaggaer Completes Acquisition of Ivoflow, Bringing AI-Powered Direct Materials Spend & Price Intelligence to Manufacturers
Sep 14, 2026
Closed $4.78 (+1.6%) on Sep 14, 2026
Financings
Convertible promissory notes and warrants
Apr 1, 2025
Closed: US$3.45M raised · unregistered warrants, exercisable immediately, expiring on the earlier of five years… · H.C. Wainwright & Co.
Dealers: H.C. Wainwright & Co. (lead)
Buyers: Lisa Conte
Insiders: President and CEO Lisa Conte, other board members and other C-suite and senior executives entered into securities purchase agreements
Use of proceeds: Working capital and other general corporate purposes
Decks
Q1 2026 Earnings Presentation
Earnings · 20 slides · May 26, 2026
Investor Presentation (May 2025)
Investor deck · 39 slides · May 9, 2025
Investor Presentation (April 2025)
Investor deck · 41 slides · Apr 21, 2025
Merger or Acquisition (November 2020)
Merger or acquisition · 30 slides · Nov 30, 2020
Jaguar Health, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 57 in the last 12 months · 357 in all · newest Nov 2, 2026 · oldest 2019
- Calls
- 20 calls with a replay · 20 with a transcript · latest Aug 19, 2026
- Decks
- 11 decks · latest May 26, 2026
Where Jaguar Health, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:JAGX · Home listing | NASDAQ | United States | USD |
| BOATS:JAGX | BOATS | United States | USD |
| gettex:1JA1 | gettex | Germany | EUR |
| Frankfurt:1JA1 | Frankfurt | Germany | EUR |
| Munich:1JA1 · This page | Munich | Germany | EUR |
| Stuttgart:1JA | Stuttgart | Germany | EUR |
Log in to ask 6ix AI your own questions about Jaguar Health, Inc.